Insights from Health Member Daniel Cody were featured in a Law360 article about how remote access to anti-addiction medication may change under the Trump administration. 

In the article, Dan describes how some are expecting the Trump administration to hold all rules proposed under the Biden administration. But if the rule is finalized, he predicts that, “’pharmacies will feel more comfortable dispensing drugs from telemedicine companies’ because it would create a formal structure for patient verification by practitioners via the Prescription Drug Monitoring Program.”

Source

Law360